This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nuvalent, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Yuting Sun: Innovator in Cancer Treatment
Introduction
Yuting Sun is a prominent inventor based in Wellesley, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Yuting Sun holds a patent for "Amino-substituted heteroaryls for treating cancers with EGFR mutations." This patent discloses amino-substituted heteroaromatic compounds, including a compound of Formula (I), along with their pharmaceutically acceptable salts and pharmaceutical compositions. The patent also outlines methods for treating or preventing cancer using these compounds.
Career Highlights
Yuting Sun is currently associated with Nuvalent, Inc., where he continues to advance his research in oncology. His work focuses on developing targeted therapies that can improve patient outcomes in cancer treatment.
Collaborations
Some of Yuting Sun's notable coworkers include Kristin Lynne Andrews and Baudouin Gerard. Their collaborative efforts contribute to the innovative environment at Nuvalent, Inc.
Conclusion
Yuting Sun's work in developing amino-substituted heteroaromatic compounds represents a significant advancement in cancer treatment. His contributions are paving the way for new therapeutic options for patients with EGFR mutations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile